Skip to main content
main-content

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

Erschienen in: Zeitschrift für Gerontologie und Geriatrie 5/2019

18.06.2019 | Themenschwerpunkt

Osteoporose und Multimorbidität

verfasst von: Dr. S. Wicklein, M. Gosch

Erschienen in: Zeitschrift für Gerontologie und Geriatrie | Ausgabe 5/2019

Einloggen, um Zugang zu erhalten

Zusammenfassung

Osteoporose ist eine systemische Knochenerkrankung, die durch verminderte Knochenfestigkeit zu einem erhöhten Frakturrisiko prädisponiert. Gerade ältere Patienten weisen ein hohes Risiko für Fragilitätsfrakturen auf. Bei diesen Patienten reicht die isolierte Betrachtung der Osteoporose nicht aus; vielmehr sollte diese im Kontext der Multimorbidität gesehen werden. Verschiedene Erkrankungen sind mit Osteoporose assoziiert, sei es durch pathophysiologische Mechanismen, gemeinsame Risikofaktoren oder aufgrund ihrer pharmakologischen Therapie. Auch geriatrische Syndrome wie etwa Sturzneigung spielen eine wesentliche Rolle. Dieser Beitrag gibt einen Überblick über Multimorbiditätsinteraktionen anhand ausgewählter häufiger Erkrankungen im höheren Lebensalter und zeigt das Vorgehen in der klinischen Praxis.
Literatur
1.
Zurück zum Zitat Bartl R, Bartl C, Gradinger R (2010) Medikamenteninduzierte Osteopathien. Medikamente, Pathogenese, Formen, Diagnostik, Prävention und Therapie. Z Rheumatol 69:135–150 CrossRefPubMed Bartl R, Bartl C, Gradinger R (2010) Medikamenteninduzierte Osteopathien. Medikamente, Pathogenese, Formen, Diagnostik, Prävention und Therapie. Z Rheumatol 69:135–150 CrossRefPubMed
2.
Zurück zum Zitat Bolland MJ, Ames RW, Horne AM, Orr-Walker BJ, Gamble GD, Reid IR (2007) The effect of treatment with a thiazide diuretic for 4 years on bone density in normal postmenopausal women. Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 18:479–486 Bolland MJ, Ames RW, Horne AM, Orr-Walker BJ, Gamble GD, Reid IR (2007) The effect of treatment with a thiazide diuretic for 4 years on bone density in normal postmenopausal women. Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 18:479–486
3.
Zurück zum Zitat Botolin S, McCabe LR (2006) Chronic hyperglycemia modulates osteoblast gene expression through osmotic and non-osmotic pathways. J Cell Biochem 99:411–424 CrossRefPubMed Botolin S, McCabe LR (2006) Chronic hyperglycemia modulates osteoblast gene expression through osmotic and non-osmotic pathways. J Cell Biochem 99:411–424 CrossRefPubMed
4.
Zurück zum Zitat Boyd CM, Vollenweider D, Puhan MA (2012) Informing evidence-based decision-making for patients with comorbidity: availability of necessary information in clinical trials for chronic diseases. PLoS ONE 7:e41601 CrossRefPubMedPubMedCentral Boyd CM, Vollenweider D, Puhan MA (2012) Informing evidence-based decision-making for patients with comorbidity: availability of necessary information in clinical trials for chronic diseases. PLoS ONE 7:e41601 CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Brown JS, Vittinghoff E, Wyman JF et al (2000) Urinary Incontinence: Does it Increase Risk for Falls and Fractures? J Am Geriatr Soc 48:721–725 CrossRefPubMed Brown JS, Vittinghoff E, Wyman JF et al (2000) Urinary Incontinence: Does it Increase Risk for Falls and Fractures? J Am Geriatr Soc 48:721–725 CrossRefPubMed
6.
Zurück zum Zitat Carbone L, Buzková P, Fink HA et al (2010) Hip fractures and heart failure: findings from the Cardiovascular Health Study. Eur Heart J 31:77–84 CrossRefPubMed Carbone L, Buzková P, Fink HA et al (2010) Hip fractures and heart failure: findings from the Cardiovascular Health Study. Eur Heart J 31:77–84 CrossRefPubMed
7.
Zurück zum Zitat Carbone LD, Cross JD, Raza SH et al (2008) Fracture risk in men with congestive heart failure risk reduction with spironolactone. J Am Coll Cardiol 52:135–138 CrossRefPubMed Carbone LD, Cross JD, Raza SH et al (2008) Fracture risk in men with congestive heart failure risk reduction with spironolactone. J Am Coll Cardiol 52:135–138 CrossRefPubMed
8.
Zurück zum Zitat Carbone LD, Johnson KC, Bush AJ et al (2009) Loop diuretic use and fracture in postmenopausal women: findings from the Women’s Health Initiative. Arch Intern Med 169:132–140 CrossRefPubMed Carbone LD, Johnson KC, Bush AJ et al (2009) Loop diuretic use and fracture in postmenopausal women: findings from the Women’s Health Initiative. Arch Intern Med 169:132–140 CrossRefPubMed
9.
Zurück zum Zitat Caughey GE, Roughead EE, Vitry AI, McDermott RA, Shakib S, Gilbert AL (2010) Comorbidity in the elderly with diabetes: Identification of areas of potential treatment conflicts. Diabetes Res Clin Pract 87:385–393 CrossRefPubMed Caughey GE, Roughead EE, Vitry AI, McDermott RA, Shakib S, Gilbert AL (2010) Comorbidity in the elderly with diabetes: Identification of areas of potential treatment conflicts. Diabetes Res Clin Pract 87:385–393 CrossRefPubMed
10.
Zurück zum Zitat Chhokar VS, Sun Y, Bhattacharya SK et al (2004) Loss of bone minerals and strength in rats with aldosteronism. American journal of physiology. Am J Physiol 287:H2023–6 Chhokar VS, Sun Y, Bhattacharya SK et al (2004) Loss of bone minerals and strength in rats with aldosteronism. American journal of physiology. Am J Physiol 287:H2023–6
11.
Zurück zum Zitat Colón-Emeric C, O’Connell MB, Haney E (2011) Osteoporosis piece of multi-morbidity puzzle in geriatric care. Mt Sinai J Med 78:515–526 CrossRefPubMed Colón-Emeric C, O’Connell MB, Haney E (2011) Osteoporosis piece of multi-morbidity puzzle in geriatric care. Mt Sinai J Med 78:515–526 CrossRefPubMed
12.
Zurück zum Zitat Cummings SR, San Martin J, McClung MR et al (2009) Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med 361:756–765 CrossRefPubMed Cummings SR, San Martin J, McClung MR et al (2009) Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med 361:756–765 CrossRefPubMed
13.
Zurück zum Zitat Dobnig H, Piswanger-Sölkner JC, Roth M et al (2006) Type 2 diabetes mellitus in nursing home patients: effects on bone turnover, bone mass, and fracture risk. J Clin Endocrinol Metab 91:3355–3363 CrossRefPubMed Dobnig H, Piswanger-Sölkner JC, Roth M et al (2006) Type 2 diabetes mellitus in nursing home patients: effects on bone turnover, bone mass, and fracture risk. J Clin Endocrinol Metab 91:3355–3363 CrossRefPubMed
14.
15.
16.
Zurück zum Zitat Fink HA, Kuskowski MA, Taylor BC, Schousboe JT, Orwoll ES, Ensrud KE (2008) Association of Parkinson’s disease with accelerated bone loss, fractures and mortality in older men: the Osteoporotic Fractures in Men (MrOS) study. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the. USA, Bd. 19, S 1277–1282 Fink HA, Kuskowski MA, Taylor BC, Schousboe JT, Orwoll ES, Ensrud KE (2008) Association of Parkinson’s disease with accelerated bone loss, fractures and mortality in older men: the Osteoporotic Fractures in Men (MrOS) study. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the. USA, Bd. 19, S 1277–1282
18.
Zurück zum Zitat Gosch M, Jeske M, Kammerlander C, Roth T (2012) Osteoporosis and polypharmacy. Z Gerontol Geriatr 45:450–454 CrossRefPubMed Gosch M, Jeske M, Kammerlander C, Roth T (2012) Osteoporosis and polypharmacy. Z Gerontol Geriatr 45:450–454 CrossRefPubMed
19.
Zurück zum Zitat Hamann C, Goettsch C, Mettelsiefen J et al (2011) Delayed bone regeneration and low bone mass in a rat model of insulin-resistant type 2 diabetes mellitus is due to impaired osteoblast function. American journal of physiology. Am J Physiol 301:E1220–8 Hamann C, Goettsch C, Mettelsiefen J et al (2011) Delayed bone regeneration and low bone mass in a rat model of insulin-resistant type 2 diabetes mellitus is due to impaired osteoblast function. American journal of physiology. Am J Physiol 301:E1220–8
20.
Zurück zum Zitat Haney EM, Chan BKS, Diem SJ et al (2007) Association of low bone mineral density with selective serotonin reuptake inhibitor use by older men. Arch Intern Med 167:1246–1251 CrossRefPubMed Haney EM, Chan BKS, Diem SJ et al (2007) Association of low bone mineral density with selective serotonin reuptake inhibitor use by older men. Arch Intern Med 167:1246–1251 CrossRefPubMed
21.
Zurück zum Zitat Häussler B, Gothe H, Göl D, Glaeske G, Pientka L, Felsenberg D (2007) Epidemiology, treatment and costs of osteoporosis in. USA, Bd. 18. the BoneEVA Study. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the, Germany, S 77–84 Häussler B, Gothe H, Göl D, Glaeske G, Pientka L, Felsenberg D (2007) Epidemiology, treatment and costs of osteoporosis in. USA, Bd. 18. the BoneEVA Study. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the, Germany, S 77–84
22.
Zurück zum Zitat Herrmann M, Tami A, Wildemann B et al (2009) Hyperhomocysteinemia induces a tissue specific accumulation of homocysteine in bone by collagen binding and adversely affects bone. Bone 44:467–475 CrossRefPubMed Herrmann M, Tami A, Wildemann B et al (2009) Hyperhomocysteinemia induces a tissue specific accumulation of homocysteine in bone by collagen binding and adversely affects bone. Bone 44:467–475 CrossRefPubMed
23.
Zurück zum Zitat Ionescu AA, Schoon E (2003) Osteoporosis in chronic obstructive pulmonary disease. European Respiratory Journal 22:64s–75s Ionescu AA, Schoon E (2003) Osteoporosis in chronic obstructive pulmonary disease. European Respiratory Journal 22:64s–75s
24.
Zurück zum Zitat Kahn SE, Zinman B, Lachin JM et al (2008) Rosiglitazone-associated fractures in type 2 diabetes: an Analysis from A Diabetes Outcome Progression Trial (ADOPT). Diabetes Care 31:845–851 CrossRefPubMed Kahn SE, Zinman B, Lachin JM et al (2008) Rosiglitazone-associated fractures in type 2 diabetes: an Analysis from A Diabetes Outcome Progression Trial (ADOPT). Diabetes Care 31:845–851 CrossRefPubMed
25.
Zurück zum Zitat Kim SM, Long J, Montez-Rath M, Leonard M, Chertow GM (2016) Hip Fracture in Patients With Non-Dialysis-Requiring Chronic Kidney Disease. J Bone Miner Res 31:1803–1809 CrossRefPubMed Kim SM, Long J, Montez-Rath M, Leonard M, Chertow GM (2016) Hip Fracture in Patients With Non-Dialysis-Requiring Chronic Kidney Disease. J Bone Miner Res 31:1803–1809 CrossRefPubMed
26.
Zurück zum Zitat Lazoura O, Papadaki PJ, Antoniadou E et al (2010) Skeletal and body composition changes in hemiplegic patients. J Clin Densitom 13:175–180 CrossRefPubMed Lazoura O, Papadaki PJ, Antoniadou E et al (2010) Skeletal and body composition changes in hemiplegic patients. J Clin Densitom 13:175–180 CrossRefPubMed
27.
Zurück zum Zitat Lechleitner M, Pils K, Roller-Wirnsberger R et al (2013) Diabetes und Osteoporose: Pathophysiologische Interaktionen und klinische Bedeutung für geriatrische Patienten. Z Gerontol Geriatr 46:390–397 CrossRefPubMed Lechleitner M, Pils K, Roller-Wirnsberger R et al (2013) Diabetes und Osteoporose: Pathophysiologische Interaktionen und klinische Bedeutung für geriatrische Patienten. Z Gerontol Geriatr 46:390–397 CrossRefPubMed
28.
Zurück zum Zitat Leslie WD, Rubin MR, Schwartz AV, Kanis JA (2012) Type 2 diabetes and bone. J Bone Miner Res 27:2231–2237 CrossRefPubMed Leslie WD, Rubin MR, Schwartz AV, Kanis JA (2012) Type 2 diabetes and bone. J Bone Miner Res 27:2231–2237 CrossRefPubMed
29.
Zurück zum Zitat Liao K‑M, Lu H‑Y (2016) A National Analysis of Complications Following Total Hip Replacement in Patients With Chronic Obstructive Pulmonary Disease. Medicine 95:e3182 CrossRefPubMedPubMedCentral Liao K‑M, Lu H‑Y (2016) A National Analysis of Complications Following Total Hip Replacement in Patients With Chronic Obstructive Pulmonary Disease. Medicine 95:e3182 CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Lim LS, Fink HA, Kuskowski MA, Taylor BC, Schousboe JT, Ensrud KE (2008) Loop diuretic use and increased rates of hip bone loss in older men: the Osteoporotic Fractures in Men Study. Arch Intern Med 168:735–740 CrossRefPubMed Lim LS, Fink HA, Kuskowski MA, Taylor BC, Schousboe JT, Ensrud KE (2008) Loop diuretic use and increased rates of hip bone loss in older men: the Osteoporotic Fractures in Men Study. Arch Intern Med 168:735–740 CrossRefPubMed
31.
Zurück zum Zitat Lui L‑Y, Stone K, Cauley JA, Hillier T, Yaffe K (2003) Bone Loss Predicts Subsequent Cognitive Decline in Older Women: The Study of Osteoporotic Fractures. J Am Geriatr Soc 51:38–43 CrossRefPubMed Lui L‑Y, Stone K, Cauley JA, Hillier T, Yaffe K (2003) Bone Loss Predicts Subsequent Cognitive Decline in Older Women: The Study of Osteoporotic Fractures. J Am Geriatr Soc 51:38–43 CrossRefPubMed
32.
Zurück zum Zitat Lynn H, Kwok T, Wong SYS, Woo J, Leung PC (2006) Angiotensin converting enzyme inhibitor use is associated with higher bone mineral density in elderly Chinese. Bone 38:584–588 CrossRefPubMed Lynn H, Kwok T, Wong SYS, Woo J, Leung PC (2006) Angiotensin converting enzyme inhibitor use is associated with higher bone mineral density in elderly Chinese. Bone 38:584–588 CrossRefPubMed
33.
Zurück zum Zitat Magaziner J, Wehren L, Hawkes WG et al (2006) Women with hip fracture have a greater rate of decline in bone mineral density than expected: another significant consequence of a common geriatric problem. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, Bd. 17, S 971–977 Magaziner J, Wehren L, Hawkes WG et al (2006) Women with hip fracture have a greater rate of decline in bone mineral density than expected: another significant consequence of a common geriatric problem. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, Bd. 17, S 971–977
34.
Zurück zum Zitat Meersch M, Schmidt C, Zarbock A (2016) Patient with chronic renal failure undergoing surgery. Curr Opin Anaesthesiol 29:413–420 CrossRefPubMed Meersch M, Schmidt C, Zarbock A (2016) Patient with chronic renal failure undergoing surgery. Curr Opin Anaesthesiol 29:413–420 CrossRefPubMed
35.
Zurück zum Zitat Mikosch P (2012) Diagnose von Osteoporose beim geriatrischen Patienten: Möglichkeiten und Grenzen. Wien Med Wochenschr 162:99–109 CrossRefPubMed Mikosch P (2012) Diagnose von Osteoporose beim geriatrischen Patienten: Möglichkeiten und Grenzen. Wien Med Wochenschr 162:99–109 CrossRefPubMed
36.
Zurück zum Zitat Montagnani A, Gonnelli S (2013) Antidiabetic therapy effects on bone metabolism and fracture risk. Diabetes Obes Metab 15:784–791 CrossRefPubMed Montagnani A, Gonnelli S (2013) Antidiabetic therapy effects on bone metabolism and fracture risk. Diabetes Obes Metab 15:784–791 CrossRefPubMed
37.
Zurück zum Zitat Motola D, Piccinni C, Biagi C et al (2012) Cardiovascular, ocular and bone adverse reactions associated with thiazolidinediones: a disproportionality analysis of the US FDA adverse event reporting system database. Drug Saf 35:315–323 CrossRefPubMed Motola D, Piccinni C, Biagi C et al (2012) Cardiovascular, ocular and bone adverse reactions associated with thiazolidinediones: a disproportionality analysis of the US FDA adverse event reporting system database. Drug Saf 35:315–323 CrossRefPubMed
38.
Zurück zum Zitat Neumann T, Sämann A, Lodes S et al (2011) Glycaemic control is positively associated with prevalent fractures but not with bone mineral density in patients with Type 1 diabetes. Diabetic medicine : a journal of the British Diabetic. Association 28:872–875 Neumann T, Sämann A, Lodes S et al (2011) Glycaemic control is positively associated with prevalent fractures but not with bone mineral density in patients with Type 1 diabetes. Diabetic medicine : a journal of the British Diabetic. Association 28:872–875
39.
Zurück zum Zitat Nuño-Solinis R, Rodríguez-Pereira C, Alonso-Morán E, Orueta JF (2014) Comorbidity and Healthcare Expenditure in Women with Osteoporosis Living in the Basque Country (Spain). J Osteoporos 2014:1–7 CrossRef Nuño-Solinis R, Rodríguez-Pereira C, Alonso-Morán E, Orueta JF (2014) Comorbidity and Healthcare Expenditure in Women with Osteoporosis Living in the Basque Country (Spain). J Osteoporos 2014:1–7 CrossRef
40.
Zurück zum Zitat Patsch JM, Kiefer FW, Varga P et al (2011) Increased bone resorption and impaired bone microarchitecture in short-term and extended high-fat diet-induced obesity. Metab Clin Exp 60:243–249 CrossRefPubMed Patsch JM, Kiefer FW, Varga P et al (2011) Increased bone resorption and impaired bone microarchitecture in short-term and extended high-fat diet-induced obesity. Metab Clin Exp 60:243–249 CrossRefPubMed
41.
Zurück zum Zitat Pietschmann P, Patsch JM, Schernthaner G (2010) Diabetes and bone. Horm Metab Res 42:763–768 CrossRefPubMed Pietschmann P, Patsch JM, Schernthaner G (2010) Diabetes and bone. Horm Metab Res 42:763–768 CrossRefPubMed
42.
Zurück zum Zitat Pijpers E, Ferreira I, de Jongh RT et al (2012) Older individuals with diabetes have an increased risk of recurrent falls: analysis of potential mediating factors: the Longitudinal Ageing Study Amsterdam. Age Ageing 41:358–365 CrossRefPubMed Pijpers E, Ferreira I, de Jongh RT et al (2012) Older individuals with diabetes have an increased risk of recurrent falls: analysis of potential mediating factors: the Longitudinal Ageing Study Amsterdam. Age Ageing 41:358–365 CrossRefPubMed
43.
Zurück zum Zitat Pouwels S, Lalmohamed A, Leufkens B et al (2009) Risk of hip/femur fracture after stroke: a population-based case-control study. Stroke 40:3281–3285 CrossRefPubMed Pouwels S, Lalmohamed A, Leufkens B et al (2009) Risk of hip/femur fracture after stroke: a population-based case-control study. Stroke 40:3281–3285 CrossRefPubMed
44.
Zurück zum Zitat Puth M‑T, Klaschik M, Schmid M, Weckbecker K, Münster E (2018) Prevalence and comorbidity of osteoporosis—a cross-sectional analysis on 10,660 adults aged 50 years and older in Germany. BMC Musculoskelet Disord 19:144 CrossRefPubMedPubMedCentral Puth M‑T, Klaschik M, Schmid M, Weckbecker K, Münster E (2018) Prevalence and comorbidity of osteoporosis—a cross-sectional analysis on 10,660 adults aged 50 years and older in Germany. BMC Musculoskelet Disord 19:144 CrossRefPubMedPubMedCentral
45.
Zurück zum Zitat Reid IR (1993) Steroid osteoporosis. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the. USA, Bd. 3, S 144–146 Reid IR (1993) Steroid osteoporosis. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the. USA, Bd. 3, S 144–146
46.
Zurück zum Zitat Roche JJW, Wenn RT, Sahota O, Moran CG (2005) Effect of comorbidities and postoperative complications on mortality after hip fracture in elderly people: prospective observational cohort study. BMJ. Clin Res Ed 331:1374 CrossRef Roche JJW, Wenn RT, Sahota O, Moran CG (2005) Effect of comorbidities and postoperative complications on mortality after hip fracture in elderly people: prospective observational cohort study. BMJ. Clin Res Ed 331:1374 CrossRef
48.
Zurück zum Zitat Schlienger RG, Kraenzlin ME, Jick SS, Meier CR (2004) Use of beta-blockers and risk of fractures. JAMA 292:1326–1332 CrossRefPubMed Schlienger RG, Kraenzlin ME, Jick SS, Meier CR (2004) Use of beta-blockers and risk of fractures. JAMA 292:1326–1332 CrossRefPubMed
49.
Zurück zum Zitat Schneider JL, Fink HA, Ewing SK, Ensrud KE, Cummings SR (2008) The association of Parkinson’s disease with bone mineral density and fracture in older women. Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, Bd. 19, S 1093–1097 Schneider JL, Fink HA, Ewing SK, Ensrud KE, Cummings SR (2008) The association of Parkinson’s disease with bone mineral density and fracture in older women. Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, Bd. 19, S 1093–1097
50.
Zurück zum Zitat Stolee P, Poss J, Cook RJ, Byrne K, Hirdes JP (2009) Risk factors for hip fracture in older home care clients. The journals of gerontology. Series A. J Gerontol A Biol Sci Med Sci 64:403–410 CrossRefPubMed Stolee P, Poss J, Cook RJ, Byrne K, Hirdes JP (2009) Risk factors for hip fracture in older home care clients. The journals of gerontology. Series A. J Gerontol A Biol Sci Med Sci 64:403–410 CrossRefPubMed
51.
Zurück zum Zitat Taylor BC, Schreiner PJ, Stone KL et al (2004) Long-term prediction of incident hip fracture risk in elderly white women: study of osteoporotic fractures. J Am Geriatr Soc 52:1479–1486 CrossRefPubMed Taylor BC, Schreiner PJ, Stone KL et al (2004) Long-term prediction of incident hip fracture risk in elderly white women: study of osteoporotic fractures. J Am Geriatr Soc 52:1479–1486 CrossRefPubMed
52.
Zurück zum Zitat Tofthagen C, Visovsky C, Berry DL (2012) Strength and balance training for adults with peripheral neuropathy and high risk of fall: current evidence and implications for future research. Oncol Nurs Forum 39:E416–24 CrossRefPubMedPubMedCentral Tofthagen C, Visovsky C, Berry DL (2012) Strength and balance training for adults with peripheral neuropathy and high risk of fall: current evidence and implications for future research. Oncol Nurs Forum 39:E416–24 CrossRefPubMedPubMedCentral
53.
Zurück zum Zitat Valsamis HA, Arora SK, Labban B, McFarlane SI (2006) Antiepileptic drugs and bone metabolism. Nutr Metab 3:36 CrossRef Valsamis HA, Arora SK, Labban B, McFarlane SI (2006) Antiepileptic drugs and bone metabolism. Nutr Metab 3:36 CrossRef
54.
Zurück zum Zitat van den Bos F, Speelman AD, Samson M, Munneke M, Bloem BR, Verhaar HJJ (2013) Parkinson’s disease and osteoporosis. Age Ageing 42:156–162 CrossRefPubMed van den Bos F, Speelman AD, Samson M, Munneke M, Bloem BR, Verhaar HJJ (2013) Parkinson’s disease and osteoporosis. Age Ageing 42:156–162 CrossRefPubMed
55.
Zurück zum Zitat van den Brand MWM, Pouwels S, Samson MM et al (2009) Use of anti-depressants and the risk of fracture of the hip or femur. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the. USA, Bd. 20, S 1705–1713 van den Brand MWM, Pouwels S, Samson MM et al (2009) Use of anti-depressants and the risk of fracture of the hip or femur. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the. USA, Bd. 20, S 1705–1713
56.
Zurück zum Zitat Yaffe K, Browner W, Cauley J, Launer L, Harris T (1999) Association Between Bone Mineral Density and Cognitive Decline in Older Women. J Am Geriatr Soc 47:1176–1182 CrossRefPubMed Yaffe K, Browner W, Cauley J, Launer L, Harris T (1999) Association Between Bone Mineral Density and Cognitive Decline in Older Women. J Am Geriatr Soc 47:1176–1182 CrossRefPubMed
Metadaten
Titel
Osteoporose und Multimorbidität
verfasst von
Dr. S. Wicklein
M. Gosch
Publikationsdatum
18.06.2019
Verlag
Springer Medizin
Erschienen in
Zeitschrift für Gerontologie und Geriatrie / Ausgabe 5/2019
Print ISSN: 0948-6704
Elektronische ISSN: 1435-1269
DOI
https://doi.org/10.1007/s00391-019-01569-5

Weitere Artikel der Ausgabe 5/2019

Zeitschrift für Gerontologie und Geriatrie 5/2019 Zur Ausgabe

Mitteilungen der DGG

Mitteilungen der DGG

Journal Club

Journal Club